I am wondering what some of the sticking points may be in the negotiations for the sale of Admedus Vaccines Pty Ltd.
Could it be that the whole future of the vaccine program is dependent on Prof. Frazer's involvement and also Uniquest who might not be keen to see the research moved to China?
Ann: Preliminary Final Report for period to 31 December 2018, page-36
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.09 |
Change
-0.210(1.37%) |
Mkt cap ! $318.9M | |||
| Open | High | Low | Value | Volume |
| $15.10 | $15.38 | $15.02 | $55.26K | 3.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98 | $15.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 779 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |